Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
09/2010
09/07/2010CA2512193C 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
09/02/2010WO2010097805A1 A process for the preparation of ranolazine
09/02/2010US20100222580 Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content
09/02/2010US20100222579 Process for the Preparation of Delmopinol and Derivatives Thereof
09/02/2010US20100222330 New Compounds
09/02/2010US20100222239 Compositions containing amide surfactants and methods for inhibiting the formation of hydrate agglomerates
09/02/2010US20100221182 Ligands for imaging cardiac innervation
09/01/2010EP2224013A1 Methods for the determination of telomerase activity using click chemistry
09/01/2010EP2222637A1 Amidine-containing compounds useful as muscarinic receptor antagonists
09/01/2010EP2222160A2 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
09/01/2010EP1979322B1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
09/01/2010EP1701945B1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof
09/01/2010EP1285651B1 Melanin concentrating hormone antagonists
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN1948298B Dopamine D3 acceptor portion agonist and its application
09/01/2010CN101821245A New compounds
09/01/2010CN101220006B Buflomedil production method
09/01/2010CN101007794B N,N'-disubstituted piperazine derivative, and its preparation method and medicinal composition and uses
08/2010
08/31/2010US7786307 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786147 used for the treatment of Parkinson's disease, Huntington disease, Alzheimer's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, ataxia, Pick's disease, Pick's disease, vision defects, Cruetzfelt-Jacob syndrome or Alzheimer's disease
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786121 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
08/31/2010CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/26/2010WO2010094285A1 Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
08/26/2010US20100216958 Methods of Preparing Renewable Butadiene and Renewable Isoprene
08/26/2010US20100216808 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
08/26/2010US20100216763 Heteroaryl Amide Derivatives
08/26/2010CA2751498A1 Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
08/25/2010EP2220062A1 New human papilloma virus inhibitors and pharmaceutical compositions containing same
08/25/2010EP2220030A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
08/25/2010EP1889827B1 Process for producing [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine
08/25/2010EP0883403B1 Method for treating sexual dysfunctions
08/25/2010CN101812143A Fluorine-containing photoinitiator and application thereof
08/25/2010CN101812142A Double functionalized aromatic ketone compounds and photoinitiator containing same
08/24/2010USRE41549 hair dyes for oxidatively dyeing human hair; comprising a developer and coupler
08/24/2010US7781580 Stilbene derivatives as new cancer therapeutic agents
08/24/2010US7781470 Aminodicarboxylic acid derivatives having pharmaceutical properties
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010CA2541066C Derivatives of indanyl-piperazines, the process for preparing them and the pharmaceutical compounds that contain them
08/24/2010CA2459752C 3-aminocarbonyl-substituted benzoylcyclohexanediones which can be used as herbicides
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/24/2010CA2257393C Compositions and methods for reducing respiratory depression
08/19/2010WO2010092811A1 Prophylactic or therapeutic agent for hypertension
08/19/2010WO2010092637A1 Water-resistant polarizing film, and process for producing same
08/19/2010WO2010092153A1 New substituted tetrahydronapthalenes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010092098A1 New production method
08/19/2010WO2010092043A1 Phenoxy acetic acid derivatives
08/19/2010US20100210842 Process for preparing
08/19/2010US20100210693 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/19/2010US20100210663 Hybrid 2-Aminotetralin and Aryl-Substituted Piperazine Compounds and their Use in Altering CNS Activity
08/19/2010US20100210653 Novel Compounds, Their Preparations and Use
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010CA2751260A1 Phenoxy acetic acid derivatives
08/19/2010CA2744949A1 New process for preparing
08/18/2010EP2218788A1 Process for the preparation of optically active cyclopentenones
08/18/2010EP2217583A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP2041104B1 Cinnamoyl-piperazine derivatives and their use as par- i antagonists
08/18/2010EP1940786B1 Biphenyl derivatives and their use in treating hepatitis c
08/18/2010EP1735275B1 Aryl sulfones and uses related thereto
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/17/2010US7777009 for modulation of chemokines; antiinflammatory agents; cancer
08/17/2010US7776924 for gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapy in conjunction with nitroreductase enzymes as hypoxia selective cytotoxins and as anticarcinogenic agents; 2((2-Bromoethyl)-2-{[(2-hydroxyethyl)amino]carbonyl}-4,6-dinitroanilino)ethyl methanesulfonate
08/17/2010US7776909 such as (5-acetyl-1-methyl-1H-pyrrol-2-yl)acetyl methanesulphonamide, used for the of treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), skin disorders, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and reperfusion injuries after ischemia
08/17/2010US7776884 Cyclic derivatives as modulators of chemokine receptors activity
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776860 Partial neutralization of the tri-hydrochloric acid salt directly results in the monohydrochloric acid salt and hydrates; serotonin receptor modulators having 5-HT1A-agonistic as well as 5-HT1D-antagonistic activity
08/17/2010CA2547591C Novel compounds and compositions as cathepsin inhibitors
08/17/2010CA2370412C Pharmaceutical compounds
08/17/2010CA2290742C Use of galt-2 inhibitor compounds to treat conditions associated with lactosylceramide
08/12/2010WO2010091382A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
08/12/2010WO2010091164A1 Inhibitors of glucosylceramide synthase
08/12/2010WO2010090954A1 Novel trifluoromethylsulfonamide gamma secretase inhibitor
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204200 Inhibitors of cathepsin s
08/12/2010CA2751987A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
08/11/2010EP2215055A1 New non-peptide derivatives as bradykinin b1 antagonists
08/11/2010EP1484301B1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
08/11/2010CN101798292A Method for preparing novel Bc1-2 protein inhibitor derived from ABT-263
08/10/2010US7772432 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide
08/10/2010US7772425 Vitamin D receptor modulators
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772251 N-sulphonylated amino acid derivatives, method for the production and use thereof
08/10/2010US7772240 used for the treatment of psychological disorders such as schizophrenia, anxiety, depression and bipolar disorder
08/10/2010US7772237 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
08/10/2010US7772229 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
08/10/2010US7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
08/10/2010US7772190 E.g., isobutyl N-methyl-N-trimethylallophanoyl-L-alanyl-D-lactate; using parasiticides and nematocides in medicine and veterinary medicine; productive and breeding animals; foods and feeds
08/10/2010US7771611 sufficiently soluble in common organic solvents to be used in nucleophilic displacement reactions to add the -OSF5 group; quaternary ammonium cation or metal cation complexed with crown compound or polyamine; reaction of thionyl tetrafluoride SOF4 with fluoride salt of the cation
08/10/2010CA2559397C Substituted morpholine and thiomorpholine derivatives
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010086177A1 Sulfamoyl- phenyl-ureido benzamidine-derivatives as antimalarial agents
08/05/2010WO2010042867A3 Activators of human pyruvate kinase
08/05/2010WO2010042165A3 Methods of making cyclic, n-amino functional triamines
08/05/2010WO2010040843A3 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 341